Jonathan Zung, Ph.D.
Chief Development Officer
Dr. Zung is Chief Development Officer of Curis, joining the company in May 2023. Prior to joining Curis, Dr. Zung served as Chief Development Officer of Evelo Biosciences where he was responsible for the operational design and execution of Evelo’s clinical programs. Dr. Zung held previous leadership roles at WCG, Covance, UCB, BMS, and Pfizer. Dr. Zung also serves on the advisory board of Saama Technologies. Dr. Zung received his Ph.D. in analytical chemistry from Emory University.